GlassScriptPhysician profile
Terry L Miller
NPI 1164498366
$7,284.89
in general payments reported to CMS, 2019-2025
43 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $204 · 2021: $737 · 2022: $1,353 · 2023: $1,468 · 2024: $1,157 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,010.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $849.85 | 2019-2025 | |
| Glaxosmithkline, LLC. | $763.60 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $482.22 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $454.53 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $422.61 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $418.88 | 2019-2025 | Jardiance, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $393.53 | 2021-2025 | Farxiga |
| Amgen INC. | $380.60 | 2019-2025 | Evenity, Prolia, Otezla |
| E.R. Squibb & Sons, L.L.C. | $298.45 | 2019-2025 | Eliquis, Camzyos |
| Abbvie INC. | $296.39 | 2022-2024 | |
| Abiomed | $211.70 | 2022-2024 | Impella |
| Kowa Pharmaceuticals America, INC. | $173.70 | 2019-2025 | Zoryve |
| Otsuka America Pharmaceutical, INC. | $172.82 | 2019-2024 | Rexulti |
| Exact Sciences Corporation | $172.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $142.34 | 2021-2024 | Dexcom G6 Transmitter |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.